TrialClinics (Sao Paulo, Brazil)2021

Phase II trial of humanized anti-Lewis Y monoclonal antibody for advanced hormone receptor-positive breast cancer that progressed following endocrine therapy.

Laura Testa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.